PCSK9 inhibition in patients with acute stroke and symptomatic intracranial atherosclerosis: protocol for a prospective, randomised, open-label, blinded end-point trial with vessel-wall MR imaging.
Yen-Chu HuangChia-Hao ChangYuan-Hsiung TsaiHsu-Huei WengLeng-Chieh LinJiann-Der LeePublished in: BMJ open (2022)
ClinicalTrials.gov, Identifier: NCT05001984; Pre-results.